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Session: Disease & Treatment 95for TRO-BMD, IGSF11). We also replicated two loci 3p21 (rs148725943, discovery
pZ6.61x10-7, replication pZ5.22x10-4 for TRO-BMD, CTNNB1) and 8q24
(rs7839059, discovery pZ2.28x10-7, replication pZ1.55x10-3 for TRO-BMD,
TNFRSF11B) that were reported previously.
Conclusion: Our findings provide useful insights that enhance our understanding of
bone development, osteoporosis, and fracture pathogenesis.
http://dx.doi.org/10.1016/j.jot.2016.06.083253
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Introduction: Themajority of long bone fractures heal successfully without compli-
cations; however fractures resulting from high impact trauma can result in delayed
healing or non-union. Early intervention could decrease patient morbidity and
reducehealth care systemcosts. Photodynamic therapy (PDT) is aminimally invasive
local treatment involving administration of a photosensitizer, which is activated by
laser light leading to the production of singlet oxygen, which can induce apoptosis
and/or necrosis of targeted cells and tissue and also influence immune responses.
PDT treatment of metastatically involved vertebrae resulted in improved vertebral
bone strength, stiffness and architecture,motivating studying PDTas an approach to
augment bone healing. The aim of this studywas to evaluate the ability of PDT treat-
ment to enhance healing in fractures exhibiting critically size defects.
Materials and Methods: Femoral fractures with critically sized defects (6 mm)
were generated in 30 adult female Sprague-Dawley rats (7 or 15 week survival).
Under general anaesthesia an 8-hole PEEK plate was attached laterally to the fe-
mur. Using a Gigly saw, a bone piece was removed followed by closure of muscu-
lature and skin. Rats were randomly allocated to three groups: control, PDT
applied either 1 day, or 7 days post fracture. A photosensitizer (Visudyne, Novartis,
Canada) was injected (1mg/kg) followed 15 minutes later by light delivery (75J;
690 nm) using a 1 cm diffuser fibre placed parallel to the fracture. The rats
were euthanized 7 or 15 weeks after induction of the fracture. mCT images of
the femur at an isotropic 13.3 mm/voxel resolution (Inveon MicroCT, Siemens, Ger-
many) were acquired and analysed (AmiraDev 5.2, FEI Visualization Science Group,
USA). Thereafter, the bone was decalcified and processed for histology. Statistical
analysis was performed using a 1-way ANOVA.
Results: All rats recovered well; however five animals were euthanized early due
to plate displacement. The total bone volume (TV) evaluated from mCT images
within the fracture gap did not show significant differences. In contrast, BMD
(gHA/cm2) trended toward higher values in the PDT treated groups compared to
controls. The fracture gap measured on mCT images of the 7 week group demon-
strated a trend toward smaller gaps in the PDT treated groups (pZ 0.0535). A sta-
tistically significant (pZ 0.0085) smaller gap is present in the PDT treated groups
after 15 weeks. Histology of the control group showed more cartilage and woven
bone formation in contrast to the PDT treated groups which exhibited more struc-
tured and mature bone.
Discussion: PDT treatment of rat femur fractures led to lower overall formation of
bone, but the bone had higher density with a decrease in the size of the fracture
gap. The increase in bone density in the PDT treated groups may suggest formation
of better quality bone (vs. quantity of bone). Histologically, with more cartilage
and woven bone present in the control group in contrast to more mature bone
and in the PDT group, the fracture healing seems to follow a different pattern,
which requires further investigation.
Funding/support: Congressionally directed Medical Research programs (CDMRP),
grant # OR090260.
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Introduction: It has been widely shown that bone formation and remodelling
would not occur unless there is already a properly established micro-vasculature.
However, blood vessels can be damaged by extrinsic causes such as chemothera-
peutic agents. Methotrexate (MTX) is an anti-metabolite chemo-agent widely
used in treatment of many diseases including childhood leukaemia and inflamma-
tory disorders. While previous studies showed that MTX can cause long-term skel-
etal side effects, whether and how it damages bone marrow micro-vasculatureremains unclear. Using a rat model and endothelial cell-culture models, we
addressed these questions. In addition, since we recently showed that the osteo-
genic, anti-oxidant, and anti-inflammatory flavonoid genistein can protect bone in
MTX-treated rats, here we also investigated effects of genistein in the recovery of
damaged blood vessels in rats treated with MTX. Furthermore, we also examined
potential treatment effects of genistein and a related flavonoid, icariin, on
viability and tube-formation ability of endothelial cells treated with MTX in vitro.
Methods: Animal studies: To study the effect of MTX on blood vessels, groups of
male (6-week-old) SpragueeDawley rats were subcutaneously injected with MTX
(0.75mg/kg) once daily for 5 days and were sacrificed on day 1, 3, 6, 9, 11, and
14. To study the protective effects of genistein, in some MTX-treated rats, genis-
tein was administrated by oral gavage (2 mg/100 g BW) for the whole period start-
ing from day 0 until one day before kill (day 9). Treatment effects on number and
sizes of bone marrow micro blood vessels were examined histologically in tibiae.
MTT viability assay: Concentration-/time- dependent treatment effects of MTX
(10nM-10mM) were examined on viability of cultured rat sinusoid endothelial cells
(SECs) and effects of 24 hour treatment with MTX plus icariin/genistein (10nM-
10mM) were also studied. Apoptosis detection by flow cytometry: SECs were
treated with MTX (1mM/mL) for 24 and 48 hours and apoptosis was detected based
on their cell surface Annexin-V expression. Tube formation assay: SECs were
treated with/without MTX (1mM), icariin or genistein (100nM-10mM) and effects
on angiogenesis were examined based on formation of tubes by SECs on Matrigel.
Results: Histological image analyses of H&E-stained tibial sections showed significant
blood vessel damage in the bone marrow of rats on days 6 and 9 and significant but
partial recovery ondays 11 and 14 following the first MTX dose.Histologyanalyses sug-
gested that genistein potentially attenuates MTX-induced blood vessel damage in the
bone marrow. Examining any cytotoxic effect of MTX on endothelial cells, MTTassays
showed that the viability of SECs was not affected after 24 hours of treatment with
MTX (10nM-10mM). However, following 48 hour treatment, viability of SECs was
reduced in a concentration-dependant manner. Flow cytometry analysis revealed
that SECs underwent apoptosis following 48 hours (but not 24 hours) treatment with
MTX (1mM). MTT assays also showed that neither genistein nor icariin treatment
affected viability of SECs viability. Tube formation assays showed a reduced tube for-
mation potential of SECs treated with MTX (1mM). Interestingly, icariin or genistein
(10mM)-treated SECs showed enhanced tube formation and icariin or genistein treat-
ment can prevent MTX-induced decrease in tube formation.
Discussion and Conclusion: Our in vivo and in vitro studies suggest that MTX
causes blood vessel damage in the bone marrow, potentially by inducing apoptosis
in endothelial cells and also interfering in the process of angiogenesis. Our in vitro
tube formation assays showed that icariin and genistein might not only promote
angiogenesis but possess some protective effect against MTX damage. Consis-
tently, our in vivo studies also showed some positive effects of genistein treatment
in reducing MTX-induced blood vessel damage in the bone marrow of rats.
http://dx.doi.org/10.1016/j.jot.2016.06.085259
INCREASED EZH2 COMBINED WITH DECREASED OSTEOBLASTOGENESIS IN
LOCAL IRRADIATION INDUCED RAT BONE LOSS
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Radiation therapy is a common treatment for cancer patients. The adverseeffects are
the insufficiency fractures and bone loss. Epigenetic regulation plays an important
role in the BMSCs differentiation. We reported here, the changes of local bone after a
single-dose 137CS irradiation exposure in rats. The bone mineral density (BMD) of the
femur and the trabecular bone volume in the tibia were significantly decreased at 12
weeks after irradiation. The micro-CT results showed that the tBMD, Tb.h, and Tb.N
were also significantly reduced after 12 weeks of irradiation exposure. The ALP-pos-
itive OB.S/BS was decreased by 42.3% after 2 weeks irradiation, and decreased by
50.8% at the 12 weeks. In contrast to the decreased expression of Runx2 and BMP2,
we found EZH2 expression was significantly increased after 2 weeks of single-dose
137CS irradiation in BMSCs. In conclusion, our results demonstrated that the single-
dose 137CS irradiation induces the loss of BMD and bone micro-architecture deteriora-
tion in rat skeleton,aswell as the increasedexpression of EZH2anddecrease of osteo-
blastogenesis after irradiation. The underlying mechanisms may be required to
further investigate the relationship.
http://dx.doi.org/10.1016/j.jot.2016.06.086261
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Myricitrin is a botanical flavonol glycoside, extracted from leaves of Myrica ceri-
fera and other plants. Abundant evidence supports myricitrin has anti-oxidative,
anti-inflammatory, and neuroprotective effects. Osteoclastic bone resorption is
